Keywords: million, profits, cangene, canadian, biotechnology, company, subsidiary

C$4 Million Profits For Cangene

Article | 07 October 1996

Print This

Canadian biotechnology company Cangene, which is a subsidiary of Apotex, has reported net income of just over C$4 million ($2.9 million) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in